EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS018-09933 
Organism
Homo sapiens 
Tissue/cell
CD19+ 
Coordinate
chr17:63150870-63152530 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr17:63151866-63151884GGAACGAGTGCAGGAAGG+6.26
FOSL1MA0477.1chr17:63151538-63151549CATGAGTCACT-6.14
Foxd3MA0041.1chr17:63151645-63151657GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr17:63151663-63151675GTTTGTTTGTTT+6.32
SPI1MA0080.4chr17:63151173-63151187CAAAAGGGGAAGTA+6.79
SPICMA0687.1chr17:63151173-63151187CAAAAGGGGAAGTA+7.31
Sox6MA0515.1chr17:63151634-63151644CCATTGTTTT+6.02
ZfxMA0146.2chr17:63152384-63152398CCCGCCTCGGCCTC+6.01
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_39767chr17:63150917-63152264Jurkat
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr176315091063151849
Number: 1             
IDChromosomeStartEnd
GH17I065154chr176315050063152835
Enhancer Sequence
TGATTTTGCA GTAAAGACAA TGTTTCATAC TTAGGCGTAT TGCCTGCAGA AGCAGACAGC 60
TTCTCATAGC CCAAGCCCGG GCCTCACCAC GGCTGTGCTC AATGTGAGGC CTCCCTCTCT 120
ATGCCACCCC TGACCTGACT ATTTATTTTT CACTCAAGGT GCCCTAGTCT TTGCAGAGAC 180
AAGCTGGCTC ACAGCTTCCC CTTTCCCTTT CTGACTGCTT AGAAGAAAGG ATGCCCCCAC 240
CAGCAATGTG TCACTCAGGT TTCCTTGCAT GCAAGCAACA GAAGACCCAC TCTTTTGTTG 300
GAGCAAAAGG GGAAGTAATT GAAATGCTAT AGAGCAGCTC ATGGAGGAAA AGGAAACACT 360
GACAAGCCAG ACTTTGGAAA GGCCAAGAAC CAGCGTAGCT CTGGGCACCC AAAGAGTGGA 420
AACAGGGGGC AGACTTTTCA GGGTGCCTTT GTGTCCCCCA TCACCTCAGA TGCAGCTGGG 480
GCAATTCTTC CTGAAGGCAT CCCTGACCCT GTCCCCCTCC CTGCCTTTGA CTGTCATTAA 540
TTTTGGCCTG AATTCTCTAC TGGACTGGGG CCCTTTAAGG GAAAGTACCT TGTCTTGCTC 600
ATCTGGGTAA TCCCAATGCT TCTCAGAGCT GTGTTTGTAA CAGATGGTTA GTAAAAGTTT 660
ATTGAATGCA TGAGTCACTT ATTGTCTGTC CTTGTGTGGA GAGTGAAGGA TTAAATCCTT 720
CAGGTGTCTT TTCTAGCTGT AGCCCTGGTC TCAGTTTACT TTCTCCATTG TTTTTGTTTG 780
TTTGTTTTGT TTTGTTTGTT TGTTTTGAGA CAGGGTCTCA TGCTGTCTCC CAGGCTGGAG 840
TGCAGTCATA AAATTATGGC TCACTGCAGC CTTGACCTCC TGGGCTCAAG TGATCCTCCT 900
GCCTCGGTTT TCCAAAGTGC TGGGATTACC AGCTTGAGAC TCCACAGCTG GCCAGTTTTC 960
TCATTTTTAA TGCAAGAATG GCAATCCCTC CCTAAGGGAA CGAGTGCAGG AAGGAAGTGA 1020
GAGAGTTCTG TGCAGGTGCT GAGTATGCAG TGGGTGCTGG ATGGTGGTGG TAGCTAGTGC 1080
TTTCCCACAC ATTGTCTGTT AACACTCACA ATAAAGTTAA GGGTAGATAT GACTGCCCAC 1140
TTTTTGCACA TGGGGTTATG GAGACCAAAG AGTTTCAGCA ACTTGCCTTC ATGTCCTTAA 1200
GCTCATTTCA TGAGTGAGCT TGAATTTCAG CCCAGCAATG TGACTCCAGA GTCCATATAT 1260
ATATTTTATT TTTACTTATA CTTTTTTTTG AGACAGGGTC TTTCTCTGTT GCTCAGGCTG 1320
GAGTGCAGTG GCACTATCTT GGCTCATTGC AGCTTCTGCC TCCTGGGTTC AAGCGATTCT 1380
CATGCCTCAG CTCCGGAGTA GCTAGGATTA CAGGCACCCA CCACCACATC CAACTAATTT 1440
TTGTATTTTT AGTAGAGATG AGATTTCACT ATGTTGGTCA GGCTGATCTC GAACTCCTGA 1500
CCTCAGGTGA TCCACCCGCC TCGGCCTCCC AAAGTGCCGG GATTACAGGC ATGAGCCACC 1560
GCGCCCAGCC CAGAGTCCAT ATTCTTATCT ACTGTCAGTT GTGCACCAGC TGCTTTCCTT 1620
CCCTGCACAC GGGGCACACT TGGTTCCTGG ATTTGGGCGA 1660